Nursing care
Tacrolimus: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Tacrolimus is a calcineurin inhibitor that prevents transplant rejection by suppressing T-cell activation. Nurses draw the trough level just before the morning dose, monitor renal function, glucose, and neurological status, and watch for tremor and hyperglycaemia alongside the expected nephrotoxicity.
What it does and why it is prescribed
Tacrolimus inhibits calcineurin, the enzyme T lymphocytes need to produce interleukin-2, and without IL-2 the immune cells that would attack a transplanted organ cannot proliferate. It is significantly more potent than cyclosporine on a milligram basis, which is why doses are measured in milligrams rather than the larger amounts used for cyclosporine.
It is prescribed after kidney, liver, heart, and other solid organ transplants, usually as part of a regimen that also includes mycophenolate and a corticosteroid. It has largely replaced cyclosporine as the calcineurin inhibitor of choice in many transplant centres because of its efficacy, though the choice between the two still varies by institution and organ type.
Nursing considerations before giving it
Confirm the most recent trough level and check it against the target range before administering the dose. The trough must be drawn immediately before the next dose, typically just before the morning dose, since levels drawn at any other time do not reflect a true trough and can prompt an incorrect dose change.
Review renal function and blood glucose, since both are affected by this drug. Give the dose on an empty stomach or consistently relative to food, as tacrolimus absorption is affected by meals and consistency matters more than the specific timing chosen. Verify no new interacting medication has been added, and do not switch between brand and generic formulations without the transplant team's explicit direction, since bioavailability differs between products.
What to monitor
Renal function is the central monitoring parameter, since tacrolimus is nephrotoxic in a dose-dependent way; track creatinine, BUN, and urine output. Blood glucose needs regular checks too, because tacrolimus can precipitate new-onset diabetes after transplant, particularly in patients with existing risk factors.
Watch for tremor, which is a common early sign of tacrolimus effect and often the first thing patients notice themselves. Monitor blood pressure, potassium, since hyperkalaemia can occur, and neurological status generally, as higher levels can cause headache, confusion, or, rarely, seizures. Trough levels are checked routinely, more frequently early after transplant and after any dose change.
Side effects versus adverse effects
Expected side effects at therapeutic levels include fine hand tremor, mild hyperglycaemia, headache, and gastrointestinal upset such as diarrhoea. These are common enough that patients should be told to expect them rather than panic at the first tremor.
Adverse, dose-related effects escalate from there: worsening nephrotoxicity with rising creatinine, significant hyperglycaemia requiring insulin, hypertension, and at high levels, neurotoxicity progressing to confusion or seizures. The distinction matters clinically because a mild tremor at a therapeutic trough is monitored, while a coarse tremor with a high trough level is reported and usually prompts a dose hold.
What to hold for and when to call
Hold the dose and notify the provider if the trough level comes back above the target range, if creatinine has risen significantly from baseline, or if the patient develops new confusion, worsening tremor, or a seizure. A missed or delayed trough result should also prompt a call before giving a scheduled dose if timing is uncertain.
Call promptly for signs of infection, since immunosuppression blunts the usual fever response and a mild-seeming infection can progress quickly. Report new or poorly controlled hyperglycaemia, urine output that drops, or blood pressure that rises sharply, all of which may need a dose adjustment rather than simply symptomatic treatment.
Patient teaching
Explain that the drug must be taken at the same time every day, consistently in relation to food, because inconsistent timing makes trough levels unreliable and puts the transplanted organ at risk. Missed doses are not made up by doubling the next one; patients should call the transplant team instead.
Teach patients to expect some hand tremor and to report it only if it worsens or interferes with daily tasks. Explain that blood sugar will be monitored because this drug can trigger diabetes, and that this risk is usually manageable with diet, monitoring, or medication if it develops. As with other immunosuppressants, grapefruit should be avoided because it raises drug levels, sun exposure should be limited given the skin cancer risk, and any fever or sign of infection warrants an urgent call rather than waiting for the next clinic visit.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
When is a tacrolimus trough level drawn?
Immediately before the next dose, which in practice usually means just before the morning dose. This gives the lowest point in the drug's cycle and is the only sample that can be compared reliably against the target range.
Does tacrolimus cause tremor?
Yes, fine hand tremor is one of the most recognisable effects of tacrolimus and often the first sign patients notice. A mild tremor at therapeutic levels is expected and monitored; a coarse or worsening tremor should be reported, as it may indicate a level above target.
Can tacrolimus cause high blood sugar?
Yes, tacrolimus can cause new-onset diabetes after transplant, particularly in patients with existing risk factors such as obesity or a family history. Glucose is checked regularly alongside renal function and trough levels.
Is tacrolimus more nephrotoxic than cyclosporine?
Both calcineurin inhibitors are nephrotoxic and require similar renal monitoring; neither is clearly worse than the other in typical use. The choice between them is usually made by the transplant centre based on organ type, side effect profile, and institutional protocol rather than nephrotoxicity alone.
More on pharmacology
Guides on this